Recently the enzyme Lysophosphatidylcholine acyltransferase 1 (LPCAT1) has emerged as a novel diagnostic marker in HCC, being overexpressed in different cancers, including HCC [49, 50]. This evidence concerns the gene LPCAT1 and hepatocellular carcinoma.